Drugs / Ro 27-2441
last change Feb 2004 re-read 3 minutes ago

Ro 27-2441

Developed for
asthma
Investigated by
Hoffmann-La Roche

Trials 1

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00048022 Oct 2002 → Feb 2004 asthma Hoffmann-La Roche Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ro 27-2441 “Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma” NCT00048022 ↗
Action Inhibit “Dual Integrin Antagonist” NCT00048022 ↗